Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients - PROVIDENCE 1


The goal of the trial was to evaluate treatment with the anti-chlamydial antibiotic rifalazil compared with placebo in patients with intermittent claudication who are highly seropositive for C. pneumonia.